Who Owns Acuvue?

• Parent Company: Johnson & Johnson
• Ownership Type: Brand division
• Company Type: Publicly Traded
• Stock Ticker: NYSE: JNJ

• Founded: 1988
• Founders: Johnson & Johnson (internal development)

• Founded: 1886
• Headquarters: New Brunswick, New Jersey, USA
• Company Type: Publicly Traded
• Stock: NYSE: JNJ
• Revenue: approximately $88.8 billion (FY2025)
• Employees: Approximately 131,000

Visit Johnson & Johnson website

• Headquarters: Jacksonville, Florida, USA
• Manufacturing / Operations: United States, Costa Rica, Belgium, Japan

Acuvue operates under Johnson & Johnson's comprehensive sustainability framework, which includes environmental initiatives, ethical manufacturing practices, and community health programs.

Environmental Sustainability: Johnson & Johnson Vision Care has committed to achieving 100% renewable electricity for its manufacturing facilities by 2025 and carbon neutrality across operations by 2030. Acuvue manufacturing facilities in Jacksonville, Florida, Limerick, Ireland, and other locations have implemented significant energy efficiency measures and waste reduction programs. The company has reduced water usage in lens manufacturing by 40% since 2018 through process optimization and water recycling systems.

Sustainable Packaging: Acuvue has implemented sustainable packaging initiatives including reduced plastic content in lens packaging, increased use of recycled materials, and packaging redesign to minimize environmental impact. The brand has eliminated approximately 500 tons of plastic packaging annually through lightweighting initiatives and material substitution.

Ethical Manufacturing: Acuvue manufacturing facilities maintain ISO 13485 medical device certification and adhere to strict quality management systems. The company implements comprehensive worker safety programs, fair labor practices, and ethical business conduct throughout its supply chain. Johnson & Johnson requires all suppliers to comply with the company's Supplier Code of Conduct, which includes environmental protection, fair labor practices, and human rights protections.

Community Health Programs: Acuvue supports community vision health initiatives through partnerships with eye care organizations, vision screening programs, and educational campaigns about eye health. The brand sponsors programs that provide vision care to underserved communities and supports research in vision science and ophthalmic innovation.

Responsible Innovation: Acuvue maintains rigorous clinical testing and safety protocols for all new lens products, with extensive clinical trials to ensure safety and efficacy before market launch. The company invests significantly in research and development to advance lens technology while maintaining high standards of patient safety and product quality.

Acuvue has received extensive recognition for innovation, product excellence, and leadership in the vision care industry.

Product Innovation Awards: Acuvue has received multiple awards for technological innovation in contact lens design and materials. The brand's introduction of daily disposable lenses, silicone hydrogel materials, and UV-blocking technology has been recognized by ophthalmic organizations and medical device innovation programs.

Design Excellence Recognition: Acuvue lens designs and packaging have received recognition from design organizations for user-friendly design, comfort innovation, and accessibility features that make lens handling easier for consumers.

Medical Device Innovation Awards: Acuvue has been acknowledged by medical device industry organizations for advancing contact lens technology and improving patient outcomes through innovative vision correction solutions. The brand's myopia management products have received particular recognition for addressing childhood vision problems.

Professional Recognition: Eye care professionals consistently rank Acuvue as the top contact lens brand for quality, reliability, and patient satisfaction. The brand maintains strong relationships with optometrists and ophthalmologists through professional education programs and clinical research partnerships.

Patient Satisfaction Awards: Acuvue consistently receives high patient satisfaction ratings in independent surveys, with particular recognition for comfort, ease of use, and visual acuity performance. The brand's daily disposable lenses are frequently recommended by eye care professionals for first-time contact lens wearers.

Industry Leadership Recognition: Acuvue has been acknowledged as the global market leader in contact lenses and recognized for its role in advancing the daily disposable lens category. Industry analysts frequently cite Acuvue's innovation leadership and market dominance as examples of successful medical device brand management.

Acuvue has maintained a strong safety record with no major product recalls, though the brand has faced some challenges typical of medical device manufacturers and competitive market dynamics.

Product Quality Issues: Acuvue has occasionally faced isolated quality control issues affecting specific lens batches, leading to voluntary recalls of limited product runs. These incidents have been promptly addressed through enhanced quality control measures and supplier management improvements, though they have occasionally affected brand reputation temporarily.

Regulatory Compliance Challenges: Like all medical device manufacturers, Acuvue operates under strict regulatory oversight from the FDA and international regulatory bodies. The brand has occasionally faced regulatory inquiries regarding product claims or manufacturing processes, though these have been resolved without major penalties or product restrictions.

Competitive Patent Disputes: Acuvue has been involved in patent disputes with competitors regarding lens materials and designs. These intellectual property conflicts are typical in the competitive medical device industry and have generally been resolved through licensing agreements or legal settlements without significantly impacting business operations.

Pricing and Access Concerns: Some consumers and healthcare providers have expressed concerns about the premium pricing of Acuvue products compared to competitors, particularly in markets with limited insurance coverage for vision care. Johnson & Johnson has addressed these concerns through patient assistance programs and insurance coverage advocacy.

Supply Chain Disruptions: Acuvue has faced occasional supply chain challenges affecting product availability, particularly during global events that impact manufacturing and distribution. These disruptions have been managed through diversified manufacturing and inventory management strategies.

Environmental Impact Concerns: Like all disposable medical products, Acuvue lenses generate environmental waste through daily disposal. The company has addressed these concerns through sustainability initiatives and packaging reduction programs, though environmental concerns about disposable products persist.